rofecoxib has been researched along with Hyperlipemia in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rofecoxib treatment reduced global and systolic LV function after ischemia-reperfusion injury in APOE*3Leiden mice." | 1.35 | Negative effects of rofecoxib treatment on cardiac function after ischemia-reperfusion injury in APOE3Leiden mice are prevented by combined treatment with thromboxane prostanoid-receptor antagonist S18886 (terutroban). ( Bekkers, ME; Corda, S; Emeis, JJ; Jukema, JW; Princen, HM; Steendijk, P; van der Hoorn, JW, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van der Hoorn, JW | 1 |
| Jukema, JW | 1 |
| Bekkers, ME | 1 |
| Princen, HM | 1 |
| Corda, S | 1 |
| Emeis, JJ | 1 |
| Steendijk, P | 1 |
| Flier, S | 1 |
| Buhre, W | 1 |
2 other studies available for rofecoxib and Hyperlipemia
| Article | Year |
|---|---|
Negative effects of rofecoxib treatment on cardiac function after ischemia-reperfusion injury in APOE3Leiden mice are prevented by combined treatment with thromboxane prostanoid-receptor antagonist S18886 (terutroban).
Topics: Animals; Apolipoprotein E3; Cyclooxygenase 2 Inhibitors; Hyperlipidemias; Immunohistochemistry; Lact | 2008 |
Selective COX-2 inhibitors: new insights into mechanisms of side effects?
Topics: Animals; Cyclooxygenase 2 Inhibitors; Hemodynamics; Hyperlipidemias; Lactones; Mice; Myocardial Infa | 2008 |